Watson-Marlow announces that construction on a new state-of-the-art manufacturing facility in the United States, with first production due in late 2022. Following an announcement made earlier this year, the company states the new facility which will be dedicated to its range of industry leading products, including peristaltic pumps, tubing, fluid path solutions, and BioPure components.
Part of Spirax-Sarco Engineering plc, a FTSE100 Company, Watson-Marlow specializes in high-quality fluid management solutions for the life sciences and process industries. This significant investment in the expansion of its manufacturing capacity will support the company’s future growth in the Americas.
Located in Devens, Massachusetts, the 150,000-square-foot facility will be close to the life sciences hub in the Cambridge/Boston area. The site will incorporate a suite of eight ISO14644-1 Class 7 cleanrooms, warehousing, and offices, with space for two further cleanrooms within the initial footprint. With segregated cleanroom and non-cleanroom production capabilities, Watson-Marlow’s new U.S. facility will strengthen the support the company provides to customers in the region across its core sectors of pharmaceutical and biotechnology, medical diagnostics, and process industries.